MDT

Medtronic
D

MDT

Arincen70/100B

Medtronic total debt 1986–2027

Medtronic's total debt was 28.15B USD on 31 July 2026, down 1.6% on a year before. At the end of fiscal year 2026 it was 27.96B USD.

Last updated 6 Nov 2026 · Next report 24 Nov 2026

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter31 Jul 202628.15B-1.59%8.82B-19.33B0.56
FY202624 Apr 202627.96B-1.95%9.22B-18.74B0.57
FY202525 Apr 202528.52B+13.95%8.97B-19.55B0.59
FY202426 Apr 202425.02B+2.71%8.01B-17.02B0.50
FY202328 Apr 202324.36B+1.04%7.96B-16.41B0.47
FY202229 Apr 202224.11B-8.62%10.57B-13.54B0.46
FY202130 Apr 202126.39B+6.42%10.82B-15.57B0.51
FY202030 Apr 202024.80B-2.05%10.95B-13.85B0.49
FY201926 Apr 201925.32B-1.74%9.85B-15.47B0.51
FY201827 Apr 201825.76B-22.87%11.23B-14.54B0.51
FY201728 Apr 201733.40B+7.70%13.71B-19.69B0.66
FY201629 Apr 201631.01B-14.11%12.63B-18.38B0.60
FY201530 Apr 201536.11B+204.14%19.48B-16.63B0.68
FY201425 Apr 201411.87B+11.84%14.24B2.37B0.61
FY201330 Apr 201310.62B+1.42%11.07B456.00M0.57
FY201230 Apr 201210.47B+8.38%2.59B-7.87B0.61
FY201130 Apr 20119.66B+1.45%2.43B-7.23B0.60
FY201030 Apr 20109.52B+40.50%3.78B-5.74B0.65
FY200930 Apr 20096.78B-2.60%1.68B-5.10B0.53
FY200830 Apr 20086.96B+14.28%1.61B-5.34B0.60
FY200730 Apr 20076.09B-23.17%3.08B-3.01B0.55
FY200630 Apr 20067.92B+223.12%6.10B-1.82B0.84
FY200530 Apr 20052.45B+3.93%3.39B939.60M0.23
FY200430 Apr 20042.36B-0.27%1.93B-431.80M0.26
FY200330 Apr 20032.37B-6.34%1.49B-872.80M0.30
FY200230 Apr 20022.53B+1,491.43%533.70M-1.99B0.39
FY200130 Apr 2001158.70M-52.21%1.23B1.07B0.03
FY200030 Apr 2000332.10M+26.47%558.10M226.00M0.07
FY199930 Apr 1999262.60M+36.77%222.10M-40.50M0.07
FY199830 Apr 1998192.00M+59.47%382.70M190.70M0.09
FY199730 Apr 1997120.40M+58.84%197.40M77.00M0.07
FY199630 Apr 199675.80M+58.91%110.30M34.50M0.04
FY199530 Apr 199547.70M-39.16%98.30M50.60M0.04
FY199430 Apr 199478.40M-23.74%108.70M30.30M0.07
FY199330 Apr 1993102.80M+15.25%77.00M-25.80M0.12
FY199230 Apr 199289.20M-9.72%100.80M11.60M0.11
FY199130 Apr 199198.80M+4.77%88.80M-10.00M0.14
FY199030 Apr 199094.30M+18.02%36.20M-58.10M0.17
FY198930 Apr 198979.90M+33.39%51.30M-28.60M0.17
FY198830 Apr 198859.90M+60.16%78.50M18.60M0.15
FY198730 Apr 198737.40M-19.74%113.70M76.30M0.10
FY198630 Apr 198646.60M—135.40M88.80M0.13

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about Medtronic's debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.